Protective effect of SIRT6 on cholesterol crystal-induced endothelial dysfunction via regulating ACE2 expression

Exp Cell Res. 2021 May 1;402(1):112526. doi: 10.1016/j.yexcr.2021.112526. Epub 2021 Feb 22.

Abstract

Sirtuins are a family of highly conserved nicotinamide adenine dinucleotide (NAD+)-dependent enzymes. Among the sirtuins, SIRT1 and SIRT6 participate in the regulation of endothelial functions and play significant roles in the physiological and pathological processes of cardiovascular diseases (CVD). Recently, our study found that minute cholesterol crystals (CC) can be endocytosed by endothelial cells and further impair endothelial functions. Since previous studies have reported that angiotensin-converting enzyme (ACE2) involves Angiotensin (Ang) II-induced inflammation in endothelial cells, this study was designed to investigate the role of SIRT1 and SIRT6 in CC-induced variation of ACE2 expression and the related mechanism between SIRT6 and ACE2. We found that ACE2 is involved in CC-induced endothelial dysfunction, which inhibits decreases in nitric oxide (NO) level and endothelial nitric oxide synthase (eNOS) activity and increases in inflammatory factors and adhesion molecules. Besides, SIRT1 and SIRT6 regulated the protein expression of ACE2 in CC-stimulated human umbilical vein endothelial cells (HUVECs). Moreover, bioinformatics analysis from the Enrichr database indicated that activating transcription factor 2 (ATF2), is highly correlated with genes that significantly upregulated after infection with the SIRT6 adenovirus vector. In CC-induced HUVECs, ACE2 expression was up-regulated in cells transfected with ATF2 siRNA. However, further mechanism studies revealed that overexpression of SIRT6 decreases the accumulation of p-ATF2 in the nucleus, but did not affect p-ATF2 expression in the cytoplasm. Taken together, these data indicated that SIRT6 regulates ACE2 might via inhibiting the accumulation of nucleus p-ATF2 in CC-induced endothelial dysfunction.

Keywords: ACE2; Cholesterol crystals; Endothelial dysfunction; SIRT6; p-ATF2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2 / genetics*
  • Angiotensin-Converting Enzyme 2 / genetics*
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Cholesterol / genetics
  • Cholesterol / metabolism*
  • Endothelial Cells / metabolism
  • Gene Expression Regulation / genetics
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / genetics
  • Oxidative Stress / genetics
  • Signal Transduction / genetics
  • Sirtuin 1 / genetics*
  • Sirtuins / genetics*

Substances

  • ATF2 protein, human
  • Activating Transcription Factor 2
  • Nitric Oxide
  • Cholesterol
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • SIRT1 protein, human
  • SIRT6 protein, human
  • Sirtuin 1
  • Sirtuins